Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system

References

• Nokleby H, Nicoll A. Risk groups and other target groups - preliminary ECDC guidance for developing influenza vaccination recommendations for the season 2010-11. Euro Surveill 2010; 15:19525
   PubMedGoogle Scholar
• Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:RR-8 1 - 62; PMID: 20689501
   PubMedGoogle Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159 - 69; http://dx.doi.org/10.1016/j.vaccine.2005.08.105; PMID: 16213065
   PubMed Web of Science ®Google Scholar
• Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003; 16:357 - 64; http://dx.doi.org/10.1128/CMR.16.3.357-364.2003; PMID: 12857772
   PubMed Web of Science ®Google Scholar
• Bedognetti D, Zoppoli G, Massucco C, Zanardi E, Zupo S, Bruzzone A, et al. Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. J Immunol 2011; 186:6044 - 55; http://dx.doi.org/10.4049/jimmunol.1004095; PMID: 21498665
   PubMed Web of Science ®Google Scholar
• Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2:659 - 66; http://dx.doi.org/10.1016/S1473-3099(02)00437-1; PMID: 12409046
   PubMed Web of Science ®Google Scholar
• Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, et al. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine 2009; 27:5043 - 53; http://dx.doi.org/10.1016/j.vaccine.2009.06.032; PMID: 19559118
   PubMed Web of Science ®Google Scholar
• Parodi V, de Florentiis D, Martini M, Ansaldi F. Inactivated influenza vaccines: recent progress and implications for the elderly. Drugs Aging 2011; 28:93 - 106; http://dx.doi.org/10.2165/11586770-000000000-00000; PMID: 21275435
   PubMed Web of Science ®Google Scholar
• de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000; 61:94 - 9; http://dx.doi.org/10.1002/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C; PMID: 10745239
   PubMed Web of Science ®Google Scholar
• Del Giudice G, Hilbert AK, Bugarini R, Minutello A, Popova O, Toneatto D, et al. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine. Vaccine 2006; 24:3063 - 5; http://dx.doi.org/10.1016/j.vaccine.2006.01.015; PMID: 16464520
   PubMed Web of Science ®Google Scholar
• Kojimahara N, Maeda A, Kase T, Yamaguchi N. Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine. Vaccine 2006; 24:5966 - 9; http://dx.doi.org/10.1016/j.vaccine.2006.05.009; PMID: 16777274
   PubMed Web of Science ®Google Scholar
• Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007; 25:6852 - 62; http://dx.doi.org/10.1016/j.vaccine.2007.07.027; PMID: 17719149
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Bacilieri S, Durando P, Sticchi L, Valle L, Montomoli E, et al. Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses. Vaccine 2008; 26:1525 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.01.019; PMID: 18294741
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Zancolli M, Durando P, Montomoli E, Sticchi L, Del Giudice G, et al. Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates. Vaccine 2010; 28:4123 - 9; http://dx.doi.org/10.1016/j.vaccine.2010.04.030; PMID: 20433807
   PubMed Web of Science ®Google Scholar
• Müller D, Szucs TD. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection 2007; 35:308 - 19; http://dx.doi.org/10.1007/s15010-007-6218-5; PMID: 17885730
   PubMed Web of Science ®Google Scholar
• Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008; 8:272; http://dx.doi.org/10.1186/1471-2458-8-272; PMID: 18673545
   PubMed Web of Science ®Google Scholar
• Hollmeyer HG, Hayden F, Poland G, Buchholz U. Influenza vaccination of health care workers in hospitals–a review of studies on attitudes and predictors. Vaccine 2009; 27:3935 - 44; http://dx.doi.org/10.1016/j.vaccine.2009.03.056; PMID: 19467744
   PubMed Web of Science ®Google Scholar
• Keeton VF, Chen AK. Immunization updates and challenges. Curr Opin Pediatr 2010; 22:234 - 40; http://dx.doi.org/10.1097/MOP.0b013e328337685b; PMID: 20125025
   PubMed Web of Science ®Google Scholar
• Chua JV, Chen WH. Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks. Crit Care 2010; 14:218; http://dx.doi.org/10.1186/cc8891; PMID: 20497595
   PubMed Web of Science ®Google Scholar
• Payler DK, Skirrow MB. Letter: Intradermal influenza vaccination. BMJ 1974; 2:727; http://dx.doi.org/10.1136/bmj.2.5921.727-a; PMID: 4852830
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). State-specific influenza vaccination coverage among adults aged > or =18 years–United States, 2003-04 and 2005-06 influenza seasons. MMWR Morb Mortal Wkly Rep 2007; 56:953 - 9; PMID: 17882124
   PubMedGoogle Scholar
• Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007; 25:8833 - 42; http://dx.doi.org/10.1016/j.vaccine.2007.10.020; PMID: 18023942
   PubMed Web of Science ®Google Scholar
• Laurent A, Mistretta F, Bottigioli D, Dahel K, Goujon C, Nicolas JF, et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007; 25:6423 - 30; http://dx.doi.org/10.1016/j.vaccine.2007.05.046; PMID: 17640778
   PubMed Web of Science ®Google Scholar
• Esposito S, Daleno C, Picciolli I, Tagliaferri L, Scala A, Prunotto G, et al. Immunogenicity and safety of intradermal influenza vaccine in children. Vaccine 2011; 29:7606 - 1
   PubMed Web of Science ®Google Scholar
• Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest 1993; 92:2587 - 96; http://dx.doi.org/10.1172/JCI116873; PMID: 8254016
   PubMed Web of Science ®Google Scholar
• Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993; 151:6535 - 45; PMID: 7504023
   PubMed Web of Science ®Google Scholar
• Spellberg B. The cutaneous citadel: a holistic view of skin and immunity. Life Sci 2000; 67:477 - 502; http://dx.doi.org/10.1016/S0024-3205(00)00653-6; PMID: 10993114
   PubMed Web of Science ®Google Scholar
• Flacher V, Bouschbacher M, Verronèse E, Massacrier C, Sisirak V, Berthier-Vergnes O, et al. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J Immunol 2006; 177:7959 - 67; PMID: 17114468
   PubMed Web of Science ®Google Scholar
• Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008; 7:1201 - 14; http://dx.doi.org/10.1586/14760584.7.8.1201; PMID: 18844594
   PubMed Web of Science ®Google Scholar
• Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?. Vaccine 2008; 26:3197 - 208; http://dx.doi.org/10.1016/j.vaccine.2008.03.095; PMID: 18486285
   PubMed Web of Science ®Google Scholar
• Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N, et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006; 24:191 - 201; http://dx.doi.org/10.1016/j.immuni.2006.01.005; PMID: 16473831
   PubMed Web of Science ®Google Scholar
• Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25:153 - 62; http://dx.doi.org/10.1016/j.immuni.2006.04.017; PMID: 16860764
   PubMed Web of Science ®Google Scholar
• Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000; 78:693 - 8; PMID: 10859864
   PubMed Web of Science ®Google Scholar
• Bryan JP, Sjogren MH, Perine PL, Legters LJ. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 1992; 14:697 - 707; http://dx.doi.org/10.1093/clinids/14.3.697; PMID: 1532914
   PubMed Web of Science ®Google Scholar
• Redfield RR, Innis BL, Scott RM, Cannon HG, Bancroft WH. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. JAMA 1985; 254:3203 - 6; http://dx.doi.org/10.1001/jama.254.22.3203; PMID: 2933535
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Vaccines: the fourth century. Clin Vaccine Immunol 2009; 16:1709 - 19; http://dx.doi.org/10.1128/CVI.00290-09; PMID: 19793898
   PubMed Web of Science ®Google Scholar
• Mantoux C. L’intradermo-re´action a la tuberculine et son interpre´tation clinique. Presse Med 1910; 18:10 - 3
   Google Scholar
• Tuft L. Active immunization against typhoid fever with particular reference to intradermal method. J Lab Clin Med 1931; 16:552
   Google Scholar
• Comparative trial of live attenuated measles vaccine in Hong Kong by intramuscular and intradermal injection. Bull World Health Organ 1967; 36:375 - 84; PMID: 5299670
   PubMed Web of Science ®Google Scholar
• Cutts FT, Clements CJ, Bennett JV. Alternative routes of measles immunization: a review. Biologicals 1997; 25:323 - 38; http://dx.doi.org/10.1006/biol.1997.0103; PMID: 9325001
   PubMed Web of Science ®Google Scholar
• McBean AM, Agle AN, Compaore P, Foster SO, McCormack WM. Comparison of intradermal and subcutaneous routes of cholera vaccine administration. Lancet 1972; 1:527 - 9; http://dx.doi.org/10.1016/S0140-6736(72)90187-0; PMID: 4110029
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Prestage H, Cole PJ, Turner GS, Bauer SP. Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine. Lancet 1981; 2:915 - 8; http://dx.doi.org/10.1016/S0140-6736(81)91402-1; PMID: 6117693
   PubMed Web of Science ®Google Scholar
• Warrell MJ, Nicholson KG, Warrell DA, Suntharasamai P, Chanthavanich P, Viravan C, et al. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985; 1:1059 - 62; http://dx.doi.org/10.1016/S0140-6736(85)92367-0; PMID: 2860284
   PubMed Web of Science ®Google Scholar
• Miller KD, Gibbs RD, Mulligan MM, Nutman TB, Francis DP. Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults. Lancet 1983; 2:1454 - 6
   PubMed Web of Science ®Google Scholar
• Goldwater PN, Woodfield DG, Ramirez AM, Anzimlt IS. Intradermal, low dose, short course hepatitis B vaccination. N Z Med J 1986; 99:703 - 5; PMID: 2950344
   PubMedGoogle Scholar
• Halsey NA, Reppert EJ, Margolis HS, Francis DP, Fields HA. Intradermal hepatitis B vaccination in an abbreviated schedule. Vaccine 1986; 4:228 - 32; http://dx.doi.org/10.1016/0264-410X(86)90134-9; PMID: 3541426
   PubMed Web of Science ®Google Scholar
• Clarke JA, Hollinger FB, Lewis E, Russell LA, Miller CH, Huntley A, et al. Intradermal inoculation with Heptavax-B. Immune response and histologic evaluation of injection sites. JAMA 1989; 262:2567 - 71; http://dx.doi.org/10.1001/jama.262.18.2567; PMID: 2530364
   PubMed Web of Science ®Google Scholar
• Connolly JH, Dick GW. Antibody response following intradermal or oral administration of formalinised poliomyelitis. Lancet 1958; 2:333 - 6; http://dx.doi.org/10.1016/S0140-6736(58)90256-3; PMID: 13576796
   PubMed Web of Science ®Google Scholar
• Samuel BU, Cherian T, Sridharan G, Mukundan P, John TJ. Immune response to intradermally injected inactivated poliovirus vaccine. Lancet 1991; 338:343 - 4; http://dx.doi.org/10.1016/0140-6736(91)90480-D; PMID: 1677699
   PubMed Web of Science ®Google Scholar
• Samuel BU, Cherian T, Rajasingh J, Raghupathy P, John TJ. Immune response of infants to inactivated poliovirus vaccine injected intradermally. Vaccine 1992; 10:135; http://dx.doi.org/10.1016/0264-410X(92)90039-M; PMID: 1311491
   PubMed Web of Science ®Google Scholar
• Nirmal S, Cherian T, Samuel BU, Rajasingh J, Raghupathy P, John TJ. Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine. Vaccine 1998; 16:928 - 31; http://dx.doi.org/10.1016/S0264-410X(97)00293-4; PMID: 9682339
   PubMed Web of Science ®Google Scholar
• Weller TH, Cheever FS, Enders JF. Immunologic reactions following the intradermal inoculation of influenza A and B vaccine. Proc Soc Exp Biol Med 1948; 67:96 - 101; PMID: 18902305
   PubMed Web of Science ®Google Scholar
• Boger WP, Liu OC. Subcutaneous and intradermal vaccination with Asian influenza vaccine. J Am Med Assoc 1957; 165:1687 - 9; PMID: 13475081
   PubMed Web of Science ®Google Scholar
• McCarroll JR, Kilbourne ED. Immunization with Asian-strain influenza vaccine: equivalence of the subcutaneous and intradermal routes. N Engl J Med 1958; 259:618 - 21; http://dx.doi.org/10.1056/NEJM195809252591304; PMID: 13590412
   PubMed Web of Science ®Google Scholar
• Klein M, Huang N. The response of infants and children to Asian influenza vaccine administered by intradermal and subcutaneous routes. J Pediatr 1961; 58:312 - 4; http://dx.doi.org/10.1016/S0022-3476(61)80260-6; PMID: 13756667
   PubMed Web of Science ®Google Scholar
• McElroy JT, Szwed JJ. Response to intradermal vaccination with A2, Hong Kong variant, influenza vaccine. N Engl J Med 1969; 281:1076; http://dx.doi.org/10.1056/NEJM196911062811921; PMID: 5343531
   PubMed Web of Science ®Google Scholar
• Phillips CA, Forsyth BR, Christmas WA, Gump DW, Whorton EB, Rogers I, et al. Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization. J Infect Dis 1970; 122:26 - 32; http://dx.doi.org/10.1093/infdis/122.1-2.26; PMID: 5433710
   PubMed Web of Science ®Google Scholar
• Foy HM, Sealey L, Cooney MK, Bor E. Efficacy of intradermally administered A2 Hong Kong vaccine. JAMA 1970; 213:130; http://dx.doi.org/10.1001/jama.213.1.130; PMID: 5467968
   PubMed Web of Science ®Google Scholar
• Marks MI, Eller JJ. Intradermal influenza immunization. Experience with Hong Kong vaccine. Am Rev Respir Dis 1971; 103:579 - 81; PMID: 5550353
   PubMed Web of Science ®Google Scholar
• Brown H, Kasel JA, Freeman DM, Moise LD, Grose NP, Couch RB. The immunizing effect of influenza A/New Jersey/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults. J Infect Dis 1977; 136:Suppl S466 - 71; http://dx.doi.org/10.1093/infdis/136.Supplement_3.S466; PMID: 606768
   PubMed Web of Science ®Google Scholar
• Brooks JH, Criep LH, Ruben FL. Intradermal administration of bivalent and monovalent influenza vaccines. Ann Allergy 1977; 39:110 - 2; PMID: 889154
   PubMedGoogle Scholar
• Halperin W, Weiss WI, Altman R, Diamond MA, Black KJ, Iaci AW, et al. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature. Am J Public Health 1979; 69:1247 - 51; http://dx.doi.org/10.2105/AJPH.69.12.1247; PMID: 507256
   PubMed Web of Science ®Google Scholar
• Herbert FA, Larke RP, Markstad EL. Comparison of responses to influenza A/New Jersey/76-A/Victoria/75 virus vaccine administered intradermally or subcutaneously to adults with chronic respiratory disease. J Infect Dis 1979; 140:234 - 8; http://dx.doi.org/10.1093/infdis/140.2.234; PMID: 479641
   PubMed Web of Science ®Google Scholar
• Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009; 27:454 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.10.077; PMID: 19022318
   PubMed Web of Science ®Google Scholar
• Hickling JK, Jones KR. Intradermal delivery of vaccines: a review of the literature and potential for development for use in low- and middle-income countries. Seattle: Program for Appropriate Technology in Health (PATH); 2009. Available at: http://www.path.org/files/TS_opt_idd_review.pdf. Accessed July 20, 2011.
   Google Scholar
• Hickling JK, Jones KR, Friede M, Zehrung D, Chen D, Kristensen D. Intradermal delivery of vaccines: potential benefits and current challenges. Bull World Health Organ 2011; 89:221 - 6; http://dx.doi.org/10.2471/BLT.10.079426; PMID: 21379418
   PubMed Web of Science ®Google Scholar
• Song JM, Kim YC, Barlow PG, Hossain MJ, Park KM, Donis RO, et al. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res 2010; 88:244 - 7; http://dx.doi.org/10.1016/j.antiviral.2010.09.001; PMID: 20851715
   PubMed Web of Science ®Google Scholar
• Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 2010; 16:915 - 20; http://dx.doi.org/10.1038/nm.2182; PMID: 20639891
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis 2010; 201:190 - 8; http://dx.doi.org/10.1086/649228; PMID: 20017632
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine 2009; 27:6932 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.08.108; PMID: 19761836
   PubMed Web of Science ®Google Scholar
• Weldon WC, Martin MP, Zarnitsyn V, Wang B, Koutsonanos D, Skountzou I, et al. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clin Vaccine Immunol 2011; 18:647 - 54; http://dx.doi.org/10.1128/CVI.00435-10; PMID: 21288996
   PubMed Web of Science ®Google Scholar
• Quan FS, Kim YC, Compans RW, Prausnitz MR, Kang SM. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release 2010; 147:326 - 32; http://dx.doi.org/10.1016/j.jconrel.2010.07.125; PMID: 20692307
   PubMed Web of Science ®Google Scholar
• Wood JM, Levandowski RA. The influenza vaccine licensing process. Vaccine 2003; 21:1786 - 8; http://dx.doi.org/10.1016/S0264-410X(03)00073-2; PMID: 12686095
   PubMed Web of Science ®Google Scholar
• Committee for Human Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines. 1997. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf. Accessed July 20, 2011.
   Google Scholar
• Klein M, Huang N. The response of infants and children to Asian influenza vaccine administered by intradermal and subcutaneous routes. J Pediatr 1961; 58:312 - 4; http://dx.doi.org/10.1016/S0022-3476(61)80260-6; PMID: 13756667
   PubMed Web of Science ®Google Scholar
• Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007; 119:1076 - 82; http://dx.doi.org/10.1542/peds.2006-3176; PMID: 17545373
   PubMed Web of Science ®Google Scholar
• Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, et al. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination. Vaccine 2008; 26:2700 - 5; http://dx.doi.org/10.1016/j.vaccine.2008.03.016; PMID: 18436353
   PubMed Web of Science ®Google Scholar
• Chiu SS, Chan KH, Tu W, Lau YL, Peiris JS. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial. Vaccine 2009; 27:4834 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.05.066; PMID: 19523908
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, et al. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine 2008; 26:6614 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.09.078; PMID: 18930093
   PubMed Web of Science ®Google Scholar
• Beran J, Ambrozaitis A, Laiskonis A, Mickuviene N, Bacart P, Calozet Y, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009; 7:13; http://dx.doi.org/10.1186/1741-7015-7-13; PMID: 19341446
   PubMed Web of Science ®Google Scholar
• Arnou R, Eavis P, Pardo JR, Ambrozaitis A, Kazek MP, Weber F. Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial. Hum Vaccin 2010; 6:346 - 54; http://dx.doi.org/10.4161/hv.6.4.10961; PMID: 20372053
   PubMed Web of Science ®Google Scholar
• Frenck RW Jr., Belshe R, Brady RC, Winokur PL, Campbell JD, Treanor J, et al. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone(®)) administered by intradermal and intramuscular route in healthy adults. Vaccine 2011; 29:5666 - 74; http://dx.doi.org/10.1016/j.vaccine.2011.06.010; PMID: 21699951
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004; 351:2286 - 94; http://dx.doi.org/10.1056/NEJMoa043555; PMID: 15525713
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198:650 - 8; http://dx.doi.org/10.1086/590434; PMID: 18652550
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009; 27:7304 - 12; http://dx.doi.org/10.1016/j.vaccine.2009.10.033; PMID: 19849996
   PubMed Web of Science ®Google Scholar
• Van Damme P, Arnou R, Kafeja F, Fiquet A, Richard P, Thomas S, et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. BMC Infect Dis 2010; 10:134; http://dx.doi.org/10.1186/1471-2334-10-134; PMID: 20504306
   PubMed Web of Science ®Google Scholar
• Morelon E, Pouteil Noble C, Daoud S, Cahen R, Goujon-Henry C, Weber F, et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine 2010; 28:6885 - 90; http://dx.doi.org/10.1016/j.vaccine.2010.08.015; PMID: 20709000
   PubMed Web of Science ®Google Scholar
• Reygrobellet C, Viala-Danten M, Meunier J, Weber F, Nguyen VH. Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials. Hum Vaccin 2010; 6:336 - 45; http://dx.doi.org/10.4161/hv.6.4.10753; PMID: 20372083
   PubMed Web of Science ®Google Scholar
• Arnou R, Frank M, Hagel T, Pre´bet A. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther 2011; 28:555 - 65; http://dx.doi.org/10.1007/s12325-011-0035-z; PMID: 21626269
   PubMed Web of Science ®Google Scholar